Bio-Rad Laboratories Inc (BIO)
277.45
+3.39
(+1.24%)
USD |
NYSE |
May 02, 13:43
Bio-Rad Laboratories Total Long Term Debt (Quarterly): 1.200B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.200B |
September 30, 2023 | 1.189B |
June 30, 2023 | 1.199B |
March 31, 2023 | 1.199B |
December 31, 2022 | 1.198B |
September 30, 2022 | 1.187B |
June 30, 2022 | 1.187B |
March 31, 2022 | 1.186B |
December 31, 2021 | 11.00M |
September 30, 2021 | 1.20M |
June 30, 2021 | 1.20M |
March 31, 2021 | 1.20M |
December 31, 2020 | 2.60M |
September 30, 2020 | 427.20M |
June 30, 2020 | 427.10M |
March 31, 2020 | 427.00M |
December 31, 2019 | 428.10M |
September 30, 2019 | 427.90M |
June 30, 2019 | 427.70M |
March 31, 2019 | 427.50M |
December 31, 2018 | 439.43M |
September 30, 2018 | 440.58M |
June 30, 2018 | 440.50M |
March 31, 2018 | 435.05M |
December 31, 2017 | 435.00M |
Date | Value |
---|---|
September 30, 2017 | 434.93M |
June 30, 2017 | 434.89M |
March 31, 2017 | 434.76M |
December 31, 2016 | 434.52M |
September 30, 2016 | 434.43M |
June 30, 2016 | 434.35M |
March 31, 2016 | 434.28M |
December 31, 2015 | 434.18M |
September 30, 2015 | 436.11M |
June 30, 2015 | 435.93M |
March 31, 2015 | 435.92M |
December 31, 2014 | 435.98M |
September 30, 2014 | 437.21M |
June 30, 2014 | 437.33M |
March 31, 2014 | 437.34M |
December 31, 2013 | 437.40M |
September 30, 2013 | 437.25M |
June 30, 2013 | 734.49M |
March 31, 2013 | 734.28M |
December 31, 2012 | 734.16M |
September 30, 2012 | 732.54M |
June 30, 2012 | 732.84M |
March 31, 2012 | 732.71M |
December 31, 2011 | 732.51M |
September 30, 2011 | 732.40M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
1.20M
Minimum
Mar 2021
1.200B
Maximum
Dec 2023
638.23M
Average
427.90M
Median
Sep 2019
Total Long Term Debt (Quarterly) Benchmarks
Agilent Technologies Inc | 2.555B |
Bruker Corp | 1.282B |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 36.56M |
Bionano Genomics Inc | 69.80M |